CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression

被引:205
|
作者
Carreno, BM
Bennett, F
Chau, TA
Ling, V
Luxenberg, D
Jussif, J
Baroja, ML
Madrenas, J
机构
[1] Univ Western Ontario, John P Robarts Res Inst, London, ON N6A 5K8, Canada
[2] Genet Inst Inc, Cambridge, MA 02140 USA
来源
JOURNAL OF IMMUNOLOGY | 2000年 / 165卷 / 03期
关键词
D O I
10.4049/jimmunol.165.3.1352
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CTLA-4 (CD152) engagement results in down-regulation of T cell activation. Two mechanisms have been postulated to explain CTLA-4 inhibition of T cell activation: negative signaling and competitive antagonism of CD28:B7-mediated costimulation, We assessed the contributions of these two mechanisms using a panel of T cell lines expressing human CTLA-4 with mutations in the cytoplasmic region. Under conditions of B7-independent costimulation, inhibition of IL-2 production following CTLA-4 engagement required the CTLA-4 cytoplasmic region. In contrast, under B7-dependent costimulation, inhibition of IL-2 production by CTLA-4 engagement was directly proportional to CTLA-4 cell surface levels and did not require its cytoplasmic region. Thus, CTLA-4 down-regulates T cell activation by two different mechanisms-delivery of a negative signal or B7 sequestration-that are operational depending on the levels of CTLA-4 surface expression. These two mechanisms may have distinct functional outcomes: rapid inhibition of T cell activation or induction of T cell anergy.
引用
收藏
页码:1352 / 1356
页数:5
相关论文
共 50 条
  • [21] MHC class II-independent and -dependent T cell expansion and B cell hyperactivity in vivo in mice deficient in CD152 (CTLA-4)
    Stohl, W
    Xu, D
    Kim, KS
    David, CS
    Allison, JP
    INTERNATIONAL IMMUNOLOGY, 2004, 16 (07) : 895 - 904
  • [22] CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
    Parry, RV
    Chemnitz, JM
    Frauwirth, KA
    Lanfranco, AR
    Braunstein, I
    Kobayashi, SV
    Linsley, PS
    Thompson, CB
    Riley, JL
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) : 9543 - 9553
  • [23] Female-Biased Incidence of Experimental Autoimmune Encephalomyelitis Reflects Sexually Dimorphic Expression of Surface CTLA-4 (CD152) on T Lymphocytes
    Luna, Rosa Maria Licon
    Koermendy, Dezsoe
    Brunner-Weinzierl, Monika C.
    GENDER MEDICINE, 2010, 7 (04) : 296 - 308
  • [24] Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells
    Iida, T
    Ohno, H
    Nakaseko, C
    Sakuma, M
    Takeda-Ezaki, M
    Arase, H
    Kominami, E
    Fujisawa, T
    Saito, T
    JOURNAL OF IMMUNOLOGY, 2000, 165 (09): : 5062 - 5068
  • [25] DEXAMETHASONE ENHANCES CTLA-4 EXPRESSION DURING T CELL ACTIVATION
    Giles, Amber
    Reid, Caitlin
    Hutchinson, Marsha-Kay
    Vinh Au
    Sonnemann, Heather
    Park, Deric
    Gilbert, Mark
    NEURO-ONCOLOGY, 2016, 18 : 88 - 88
  • [26] Dexamethasone enhances CTLA-4 expression during T cell activation
    M. Xia
    J. Gasser
    U. Feige
    Cellular and Molecular Life Sciences CMLS, 1999, 55 : 1649 - 1656
  • [27] Dexamethasone enhances CTLA-4 expression during T cell activation
    Xia, M
    Gasser, J
    Feige, U
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (12) : 1649 - 1656
  • [28] Two different forms of human CTLA-4 proteins following peripheral T cell activation
    Chun, T
    Choi, HJ
    Chung, YH
    IMMUNOLOGY LETTERS, 2004, 91 (2-3) : 213 - 220
  • [29] Regulation of T-cell activation by CD28 and CTLA-4
    Nagel, T
    Kalden, JR
    Manger, B
    MEDIZINISCHE KLINIK, 1998, 93 (10) : 592 - 597
  • [30] CTLA-4 CAN FUNCTION AS A NEGATIVE REGULATOR OF T-CELL ACTIVATION
    WALUNAS, TL
    LENSCHOW, DJ
    BAKKER, CY
    LINSLEY, PS
    FREEMAN, GJ
    GREEN, JM
    THOMPSON, CB
    BLUESTONE, JA
    IMMUNITY, 1994, 1 (05) : 405 - 413